Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Member Organization News

Millendo Therapeutics Sets Michigan Record by Raising $62 Million

Tuesday, January 05, 2016   (0 Comments)
Share |

Ann Arbor-based Company Also Announces Partnership with Drug Giant AstraZeneca

Ann Arbor-based Millendo Therapeutics Inc. announced Tuesday morning it has raised a venture capital round of $62 million, the largest VC round for a drug development company in Michigan history.

The company simultaneously announced an exclusive licensing agreement with the London-based pharmaceutical giant AstraZeneca plc to continue human trials and commercialization of a drug it has developed to fight polycystic ovary syndrome, the most common endocrine disease in women.

Read More

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by®  ::  Legal